The U.S. Food and Drug Administration issued a recall notice Tuesday for several lots of six products, including Walgreens Acne Control Cleanser, Proactiv Skin Smoothing Exfoliator, SLMD Benzoyl ...

The U.S. Food and Drug Administration issued a recall notice Tuesday for several lots of six products, including Walgreens Acne Control Cleanser, Proactiv Skin Smoothing Exfoliator, SLMD Benzoyl ...

The FDA tested 95 products containing benzoyl peroxide, an ingredient widely used to treat acne that can form benzene as a byproduct. It found that six products could have more benzene than usual.

The U.S. Food and Drug Administration (FDA) has announced a recall for select acne treatment products after testing revealed elevated levels of benzene, a chemical linked to cancer. The agency […] The ...

Acne creams from retailers including Walgreens, La Roche-Posay and Proactiv have been voluntarily recalled due to elevated levels of a potentially cancer-causing agent.

The Food and Drug Administration is asking retailers to remove a small number of acne creams from their shelves that contain ...

The global anorexiant market is set for significant expansion, with a projected compound annual growth rate (CAGR) of 5.1% over the forecast period, according to a recent study by Future Market ...

According to a comprehensive report from The Insight Partners, 'dPCR and qPCR Market Size and Forecast 2022 - 2030, Global ...

Roche's rejuvenated drug portfolio and increased free cash flow signal a potential turnaround, but long-term charts and past performance warrant caution. Diagnostics business and AI integration ...

Public Service Commissioner Sir Brian Roche fears the sheer number of entities, departments and agencies – some of which are small – creates inefficiencies and duplication.

Whitefish native Mac Roche was officially hired to coach the Braves during the Kalispell School District school board meeting Tuesday. The board also approved the hiring of Jaimie Nelson as ...

Newleos Ther­a­peu­tics emerged Thurs­day with $93.5 mil­lion and a bun­dle of oral small mol­e­cules that it li­censed from Roche, fur­ther demon­strat­ing that the phar­ma-to-start ...